Search

Change is constant. We know that the pace is only accelerating in health care. The editors of Drug Topics' recognize the myriad challenges you face in improving the lives of [...]

The article focuses on the passage of the healthcare reform in the U.S. and the farewell of Jordan Lieberma as chief executive officer (CEO) of this journal.

The author comments on the plan of the U.S. Congress to make a decision in the health care reform debate in 2009. He considers the decision as a multidimensional contest that will likely have no clear winner. It notes the relationship between the health care policy and political communities in the country.

A review of the article "Inside the Race to Rescue a Health Care Site, and Obama," which appeared in a 2013 issue of "New York Times" is presented.

The author shares his views on whether pharmacists in the U.S. should educate patients about the Affordable Care Act (ACA), also known as Obamacare. Both the public and health care professionals are expected to have a bumpy transition as the ACA rolls out. The results of a survey revealed that majority of people wants community pharmacists to educate patients about Obamacare.

The author shares his views about the impact of health care reform on professionals and pharmacists. He notes that importance of being guided by one's core beliefs during periods of uncertainty, and the individual's personal responsibility to manage his or her own health and those of their families. The author cites the need for the pharmacy community to be more entrepreneurial and innovative in response to changes in the health care system.

The article contemplates on the future of the U.S. health care reform. Highlighting 2011 is the enactment of the Patient Protection and Affordable Care Act (PPACA), which is considered the most controversial domestic accomplishment of U.S. President Barack Obama. 2012, however, is projected to be challenging, particularly with the announcement of the U.S. Supreme Court to hear opposition to the sweeping health care reform law.

The author comments on the U.S. Patient Protection and Affordable Care Act (PPACA). He asserts his opposition to provisions of PPACA on its effects to health care professionals and patients. He argues that though the PPACA will expand the power and influence of the U.S. government since Medicare, it will not be a true reform. He highlights that the U.S. government will interfere in business affairs of health care professionals and in patient-provider relationship.

The author comments on the passage of the U.S. health care reform bill and its implications for pharmacists. He cites the results of two polls which showed the negative views of pharmacists and the public against the reform bill. Major concerns about the reforms' impact include higher costs for health care, less job security for pharmacists, and erosion of physicians' decision-making authority.